Cationic peptides from scorpion venom can stimulate and inhibit polymorphonuclear granulocytes

Toxicon

Volumn 40, Issue 12, 2002, Pages 1679-1683

  Willems, Jean ^a   Noppe, Wim ^a   Moerman, Leentje ^a   Van der Walt, Jürg ^b   Verdonck, Fons ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Chemotaxis; Exocytosis; Granulocytes; NADPH oxidase; Scorpion toxin

Indexed keywords

AMINO ACID; PEPTIDE; SCORPION VENOM; SUPEROXIDE;

ARTICLE; CHEMOTAXIS; EXOCYTOSIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SCORPION; SEQUENCE HOMOLOGY; SOUTH AFRICA;

AMINO ACID SEQUENCE; ANIMALS; CATIONS; CHEMICAL FRACTIONATION; CHEMOTAXIS; CIRCULAR DICHROISM; DOSE-RESPONSE RELATIONSHIP, DRUG; EXOCYTOSIS; HUMANS; MOLECULAR SEQUENCE DATA; NEUTROPHILS; PEPTIDES; SCORPION VENOMS; SCORPIONS; SUPEROXIDES;

SCORPIONES;

EID: 0036891040     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(02)00183-6     Document Type: Article

References (17)

1. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir. Res. 1:2000;141-150.
2. Bergmeyer H.U., Bernt E. Bermeyer H.U. Methods of Enzymatic Analysis. Methods of Enzymatic Analysis. vol. 2:1974;574-579 Verlag Chemie, Weinheim.
3. Chung C.Y., Funamoto S., Firtel R.A. Signalling pathways controlling cell polarity and chemotaxis. Trends Biochem. Sci. 26:2001;557-566.
4. Conde R., Zamudio F.Z., Rodriguez M.H., Possani L.D. Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom. FEBS Lett. 471:2000;165-168.
5. Cornut I., Büttner K., Dasseux J.L., Dufourcq J. The amphipathic α helix concept. Application to the de novo design of ideally amphipathic Leu, Lys peptides with hemolytic activity higher than that of mellitin. FEBS Lett. 349:1994;29-33.
6. Dusi S., Donini M., Rossi F. Mechanisms of NADPH oxidase activation in human neutrophils: p67 phox is required for the translocation of rac 1 but not rac 2 from cytosol to the membranes. Biochem. J. 308:1995;991-994.
7. Froy O., Gurevitz M. Membrane potential modulators: a thread of scarlet from plants to humans. Faseb J. 12:1998;1793-1796.
8. Hancock R.E. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet (Infect. Dis.). 1:2001;156-164.
9. Hancock R.E., Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:1998;82-88.
10. Mousli M., Bueb J.L., Branner C., Rouot B., Landry Y. G-protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol. Sci. 11:1990;358-362.
11. Panaro M.A., Mitolo V. Cellular responses to fMLP challenging: a mini review. Immunopharmacol. Immunotoxicol. 21:1999;397-419.
12. Possani L.D., Becerril B., Delepierre M., Tytgat J. Scorpion toxins specific for Na-channels. Eur. J. Biochem. 264:1999;287-300.
13. Shi J., Ross C.R., Leto T.L., Blecha F. PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox. Proc. Natl Acad. Sci. USA. 93:1996;6014-6018.
14. Tisch D., Sharoni Y., Danilenko M., Aviram I. The assembly of neutrophil NADPH oxidase: effects of mastoparan and its synthetic analogues. Biochem. J. 310:1995;715-719.
15. Tisch-Idelson D., Fridkin M., Wientjes F., Aviram I. Structure-function relationship in the interaction of mastoparan analogs with neutrophil NADPH oxidase. Biochem. Pharmacol. 61:2001;1063-1071.
16. Verdonck F., Bosteels S., Desmet J., Moerman L., Noppe W., Willems J., Tytgat J., Van der Walt J. A novel class of pore-forming peptides in the venom of Parabuthus Schlechteri Purcell. Cimbebasia. 16:2000;247-260.
17. Willems J., Joniau M., Cinque S., Van Damme J. Human granulocyte chemotactic peptide (IL-8) as a specific degranulator: comparison with other monokines. Immunology. 67:1989;540-542.